SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-028930
Filing Date
2022-11-08
Accepted
2022-11-08 16:18:12
Documents
53
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fhtx-20220930.htm   iXBRL 10-Q 998577
2 EX-31.1 fhtx-20220930xex311.htm EX-31.1 10354
3 EX-31.2 fhtx-20220930xex312.htm EX-31.2 10333
4 EX-32.1 fhtx-20220930xex321.htm EX-32.1 4403
5 EX-32.2 fhtx-20220930xex322.htm EX-32.2 4388
  Complete submission text file 0001628280-22-028930.txt   4247708

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fhtx-20220930.xsd EX-101.SCH 29555
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fhtx-20220930_cal.xml EX-101.CAL 46513
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fhtx-20220930_def.xml EX-101.DEF 116047
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fhtx-20220930_lab.xml EX-101.LAB 369628
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fhtx-20220930_pre.xml EX-101.PRE 225465
47 EXTRACTED XBRL INSTANCE DOCUMENT fhtx-20220930_htm.xml XML 660606
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39634 | Film No.: 221369162
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences